A recent analysis on GLP-1 use in New York City showed that theres a higher concentration of GLP-1 use for weight management in wealthy neighborhoods
Monitoring includes weight tracking, blood pressure checks, review of side effects (nausea, vomiting, constipation), and annual assessment of kidney and pancreatic function
This is far from superficial
In response, Novo Nordisk is advancing several next-generation candidates: Oral Wegovy is expected to receive FDA review by late 2025, potentially becoming the first oral GLP-1 approved for weight management
Your immune system functions best when it has all the nutrients it needs to do its job
At Functional Health Center, we offer a Functional Medicine approach to metabolic health, utilizing GLP-1 receptor agonists as a powerful, evidence-based tool within a comprehensive, holistic wellness framework